Personal Introduction:
-
Former Director of the Oncology Department at the Second Affiliated Hospital of Chongqing Medical University
-
Clinical and research experience in the United States at the University of Illinois at Chicago and the University of Missouri Hospital
-
Member of the Thermotherapy Committee of the Chinese Anti-Cancer Association
-
Member of the Immunotherapy Subcommittee of the Chinese Research Hospital Association
-
Vice Chairman of the Oncology Subcommittee of the Chongqing Medical Association
-
Recognized as one of the first “Shachi Famous Doctors” in Shapingba District, Chongqing
-
Selected as one of the second batch of academic leaders in Chongqing
-
Executive Director of the Chongqing Integrative Medicine Association
-
Vice Chairman of the Tumor Nutrition and Supportive Care Subcommittee of the Chongqing Anti-Cancer Association
-
Senior Title Evaluation Expert for the Chongqing Health Talent Committee
-
Reviewer for the National Natural Science Foundation of China; expert reviewer for project evaluation in Chongqing, Sichuan, Guangxi, and Hebei
-
Principal investigator of over 10 research projects including the National Natural Science Foundation, military PR projects, Ministry of Personnel's Overseas Study Fund, and projects from the Chongqing Science and Technology Commission
-
Editorial board member of Biomarker Research, Chinese Emergency Medicine, and Chinese Journal of Pulmonary Diseases
-
Has supervised over 50 graduate students and published more than 80 academic papers, including over 20 indexed by SCI
Areas of Expertise:
-
Cancer Screening and Early Diagnosis: Skilled in identifying and differentiating benign and malignant conditions such as pulmonary nodules, thyroid nodules, and lymphadenopathy.
-
Multidisciplinary Treatment (MDT) for Cancer: Specialized in the standardized, personalized, and comprehensive treatment of lung cancer, breast cancer, gastrointestinal cancers, and gynecologic cancers.
-
Comprehensive Management of Cancer Patients: Proficient in managing cancer-related complications such as pleural and peritoneal effusions, thrombosis, cancer pain, fever, and treatment-related side effects including bone marrow suppression and immune-related toxicities.